NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
NOTE 1 – BASIS OF PRESENTATION
These interim unaudited condensed consolidated financial statements have been prepared in accordance with United States of America (“U.S.”) generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting and should be read in conjunction with the consolidated financial statements and related notes of Hudson Global, Inc. and its subsidiaries (the “Company”) filed in its Annual Report on Form 10-K for the year ended December 31, 2023.
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of operating revenues and expenses. These estimates are based on management’s knowledge and judgments. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the Company’s financial position, results of operations, and cash flows at the dates and for the periods presented have been included. The results of operations for interim periods are not necessarily indicative of the results of operations for the full year. The condensed consolidated financial statements include the accounts of the Company and all of its wholly owned subsidiaries. Intra-entity balances and transactions between and among the Company and its subsidiaries have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current year presentation with no material impact on the condensed consolidated financial statements. For more information, see Note 2 to the Condensed Consolidated Financial Statements.
NOTE 2 – DESCRIPTION OF BUSINESS
The Company delivers Recruitment Process Outsourcing (“RPO”) services consisting of recruitment and contracting solutions tailored to the individual needs of primarily mid-to-large multinational companies. The Company operates directly in fourteen countries with three reportable geographic business segments: the Americas, Asia Pacific, and Europe, Middle East, and Africa ("EMEA"). The Company’s RPO delivery teams utilize recruitment process methodologies and project management expertise to meet clients’ ongoing business needs. The Company’s RPO services include complete recruitment outsourcing, project-based outsourcing, contingent workforce solutions, and recruitment consulting for clients’ permanent staff hires. Hudson’s RPO services leverage the Company’s consultants, supported by the Company’s specialists, in the delivery of its proprietary methods to identify, select, and engage the best-fit talent for critical client roles. In addition, the Company provides RPO clients with a range of outsourced professional contract staffing services and managed service provider services offered sometimes on a standalone basis and sometimes as part of a blended total talent solution. These services draw upon a combination of specialized recruiting and project management competencies to deliver a wide range of solutions. Hudson RPO-employed professionals - either individually or as a team - are placed with client organizations for a defined period of time based on specific business needs of the client.
On March 12, 2024 and April 15, 2024, the Company announced that it had entered into strategic agreements with Executive Solutions and Striver, respectively, both of which are Dubai-based talent solutions companies. These agreements allowed the Company to expand its global footprint and client base in the Middle East market. The Company evaluated the agreements under ASC 805 “Business Combinations” and determined that the transactions did not qualify as either business combinations or asset purchases. Payments associated with these agreements were classified as compensation expense and were included in the “Salaries and related” caption on the Company’s Condensed Consolidated Statements of Operations.
In February 2024, Hudson RPO announced an expansion of its service offerings to include executive search in North America, focusing on Life Sciences and Human Resources. This expansion, coupled with the Company’s existing RPO strategy, provides a comprehensive talent acquisition approach, enabling clients to develop streamlined and centralized hiring strategies within a flexible and scalable total talent solution. This service offering better positions the Company as a strategic partner helping clients to implement successful business strategies.
On November 15, 2023, Hudson announced the appointment of Jacob “Jake” Zabkowicz as Global Chief Executive Officer of Hudson RPO. Mr. Zabkowicz leads the vision, strategy, and execution of Hudson RPO’s growth plan, while Jeff Eberwein, Chief Executive Officer of Hudson Global, Inc., continues to focus on capital allocation, acquisitions, corporate strategy, and maximizing shareholder value.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
On October 31, 2023, Hudson completed its acquisition of Hudson Global Resources (Singapore) Pte. Ltd. (“Hudson Singapore”), a provider of recruitment services primarily to clients operating in Singapore. Hudson Singapore has a 30-year track record of senior placements and project recruitment work across Southeast Asia including Singapore, Malaysia, the Philippines, Vietnam, Thailand, and Indonesia.
See Note 15 to the Condensed Consolidated Financial Statements for further details regarding the Company’s reportable segments: Americas, Asia Pacific, and EMEA.
NOTE 3 – ACCOUNTING PRONOUNCEMENTS
Recent Accounting Standard Update Not Yet Adopted
In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”. This standard provides additional disclosures about significant expenses in operating segments. The guidance is effective for all entities, for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is evaluating the effect of adopting this new accounting guidance, and will adopt the guidance when it becomes effective.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which modifies FASB Accounting Standards Codification 740 to enhance the transparency and decision usefulness of income tax disclosures. ASU No. 2023-09 is effective on a prospective basis for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the effect of adopting this new accounting guidance, and will adopt the guidance when it becomes effective.
Adoption of New Accounting Pronouncements
On January 1, 2023, the Company adopted Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”. This update was issued by the Financial Accounting Standards Board (the “FASB”) in June 2016. This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) and replaces the methodology that recognizes impairment of financial instruments when losses have been incurred with a methodology that recognizes impairment of financial instruments when losses are expected. The new standard requires entities to use a forward-looking “expected loss” model for most financial instruments, including accounts receivable and unbilled services that is based on historical information, current information, and reasonable and supportable forecasts.
As a result of adopting the new standard, the Company recognized a cumulative increase to allowances for accounts receivable and unbilled services and a reduction to the 2023 opening balance of retained earnings of $51. Comparative periods prior to the adoption of this standard and their respective disclosures have not been adjusted. The adoption of ASU 2016-13 did not have a material impact on the Company’s Condensed Consolidated Financial Statements.
NOTE 4 – REVENUE RECOGNITION
Nature of Services
We account for a contract when both parties to the contract have approved the contract, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable. Revenues are recognized over time, using an input or output method, as the control of the promised services is transferred to the client in an amount that reflects the consideration we expect to be entitled to in exchange for those services. The majority of our contracts are short-term in nature as they include termination clauses that allow either party to cancel within a short termination period, without cause. Revenue includes billable travel and other reimbursable costs and is reported net of sales or use taxes collected from clients and remitted to taxing authorities.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
We generally determine standalone selling prices based on the prices included in our client contracts, using expected cost plus profit, or other observable prices. The price as specified in our client contracts is generally considered the standalone selling price as it is an observable input that depicts the price as if sold to a similar client in similar circumstances. Certain client contracts have variable consideration, including usage-based fees that increase the transaction price and volume rebates or other similar items that generally reduce the transaction price. We estimate variable consideration using the expected value method based on the terms of the client contract and historical evidence. These amounts may be constrained and are only included in revenue to the extent we do not expect a significant reversal when the uncertainty associated with the variable consideration is resolved. Other than bonuses to be paid to contractors, on behalf of our clients, our estimated amounts of variable consideration subject to constraints are not material, and we do not believe that there will be significant changes to our estimates. Certain contract employees are entitled to performance bonuses at the sole discretion of the client and are constrained until approved. No bonuses were approved and paid to our contract employees on behalf of our clients in the nine months ended September 30, 2024. Bonuses of $0.5 million were approved and paid to our contract employees in the nine months ended September 30, 2023.
We record accounts receivable when our right to consideration becomes unconditional. Contract assets primarily relate to our rights to consideration for services provided that such rights to consideration are conditional on satisfaction of future performance obligations. A contract liability for deferred revenue is recorded when consideration is received, or is unconditionally due, from a client prior to transferring control of services to the client under the terms of a contract. Deferred revenue balances typically result from advance payments received from clients prior to transferring control of services. Other than deferred revenue, we do not have any material contract assets or liabilities as of and for the nine months ended September 30, 2024 and 2023. As of September 30, 2024 and December 31, 2023, deferred revenue was $108 and $96, respectively.
Payment terms vary by client and the services being provided to the client. We consider payment terms that exceed one year to be extended payment terms. Substantially all of the Company’s contracts include payment terms of 90 days or less, and we do not extend payment terms beyond one year.
We primarily record revenue on a gross basis in the Condensed Consolidated Statements of Operations and Comprehensive Income based upon the following key factors:
•We maintain the direct contractual relationship with the client and are responsible for fulfilling the service promised to the client.
•We maintain control over our contractors while the services to the client are being performed, including our contractors’ billing rates, and are ultimately responsible for paying them.
RPO. We provide complete recruitment outsourcing, project-based outsourcing, and recruitment consulting services for clients’ permanent staff hires. We recognize revenue for our RPO over time in an amount that reflects the consideration we expect to be entitled to and have an enforceable right to payment in exchange for our services. The client simultaneously receives and consumes the benefits of the services as they are provided. The transaction prices contain both fixed fees and variable consideration. Variable consideration is constrained by candidates accepting offers of permanent employment. We recognize revenue on fixed fees as the performance obligations are satisfied and variable fees as the constraint is lifted. We do not incur incremental costs to obtain our RPO contracts. The costs to fulfill these contracts are expensed as incurred.
We recognize permanent placement revenue when employment candidates accept offers of permanent employment. We have a substantial history of estimating the financial impact of permanent placement candidates who do not remain with our clients through a guarantee period. Fees to clients are generally calculated as a percentage of the new employee’s annual compensation. No fees for permanent placement services are charged to employment candidates.
Contracting. We provide clients with a range of outsourced professional contract staffing services and managed service provider services, sometimes offered on a standalone basis and sometimes offered as part of a blended total talent solution. We recognize revenue for our contracting services over time as services are performed in an amount that reflects the consideration we expect to be entitled to and have an enforceable right to payment in exchange for our services, which is generally calculated as hours worked multiplied by the agreed-upon hourly bill rate. The client simultaneously receives and consumes the benefits of the services as they are provided. We do not incur incremental costs to obtain our contracts for
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
outsourced professional contract staffing services and managed service provider services. The costs incurred to fulfill these contracts are expensed as incurred.
Unsatisfied performance obligations. As a practical expedient, we do not disclose the value of unsatisfied performance obligations for (i) contracts with an expected original duration of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
Disaggregation of Revenue
The following table presents our disaggregated revenues by revenue source. For additional information on the revenues by geographical segment, see Note 15 to the Condensed Consolidated Financial Statements.
Three Months Ended September 30,
2024
2023
RPO
$
17,569
$
18,876
Contracting
19,284
20,522
Total Revenue
$
36,853
$
39,398
Nine Months Ended September 30,
2024
2023
RPO
$
51,177
$
62,316
Contracting
55,279
65,051
Total Revenue
$
106,456
$
127,367
NOTE 5 – ACCOUNTS RECEIVABLE, NET
Accounts receivable balances are composed of trade and unbilled receivables. Unbilled accounts receivable represent revenue recorded in advance of processing formal invoices pursuant to the completion of contract provisions and, generally, become billable at contractually specified dates. Unbilled receivables of $7,106 and $5,163 as of September 30, 2024 and December 31, 2023, respectively, are expected to be invoiced and collected within one year. The Company records accounts receivable when its right to consideration becomes unconditional. Contract assets primarily relate to our rights to consideration for services provided that they are conditioned on satisfaction of future performance obligations. Accounts receivable, net, are stated at the amount the Company expects to collect, which is net of estimated losses resulting from the inability of its customers to make required payments.
The Company generally establishes customer credit limits and estimates the allowance for credit losses on a country or geographic basis. Customer credit limits are based upon an initial evaluation of the customer’s credit quality and we adjust that limit accordingly based upon ongoing credit assessments of the customer, including payment history and changes in credit quality. Consistent with our adoption of ASU 2016-13, effective January 1, 2023 (refer to Note 3 – Accounting Pronouncements), the allowance for expected credit losses is determined based on an assessment of past collection experience as well as consideration of current and future economic conditions and changes in our customer collection trends.
The following table summarizes the components of “Accounts receivable, net” as presented on the Condensed Consolidated Balance Sheets:
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
September 30,
December 31,
Accounts Receivable:
2024
2023
Billed receivables
$
17,741
$
14,925
Unbilled receivables
7,106
5,163
Accounts Receivable, Gross
$
24,847
$
20,088
Allowance for expected credit losses
(372)
(378)
Accounts Receivable, Net
$
24,475
$
19,710
The following table summarizes the total provision for expected credit losses and write-offs:
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
2024
2023
Beginning balance
$
378
$
102
$
378
$
51
Provision for expected credit losses
—
44
3
44
Write-offs
(6)
—
(9)
—
Cumulative-effect adjustment from adoption of ASU 2016-13, Credit Losses
—
—
—
51
Ending Balance
$
372
$
146
$
372
$
146
NOTE 6 – ACQUISITIONS
Hudson Global Resources (Singapore) Pte. Ltd.
On October 31, 2023, the Company entered into a share purchase agreement by and among, Hudson RPO Limited, a wholly owned subsidiary of the Company (“Buyer”), and Hudson Global Resources (Australia) Pty Limited (“Seller”), and completed the acquisition by Hudson RPO Limited of all of the shares of Hudson Global Resources (Singapore) Pte. Ltd. (“Singapore Acquisition”).
Hudson Singapore is a provider of recruitment services primarily to clients operating in Singapore, with a 30-year track record of senior placements and project recruitment work across Southeast Asia including Singapore, Malaysia, the Philippines, Vietnam, Thailand, and Indonesia.
In connection with the Singapore Acquisition, Seller received $2,546 in cash, subject to certain adjustments, at the closing of the Singapore Acquisition. Additionally, Seller has a contingent right to receive earn-out payments not to exceed approximately $317, based upon the achievement of certain performance thresholds and subject to the satisfaction of certain conditions.
The Singapore Acquisition was accounted for as a business combination under the acquisition method of accounting. The purchase price of $2,574, consisted of the amount paid in cash of $2,546 and a preliminary working capital adjustment of $28. Potential contingent earn-out payments of up to approximately $317 were excluded from the purchase price, and no fair value was assigned to the earn-out, as the seller did not achieve the associated revenue milestones through December 2023. The purchase price, which included $491 of cash and cash equivalents acquired, was allocated to the net tangible and intangible assets and liabilities based on their fair values on the acquisition date of October 31, 2023, with the excess recorded as goodwill. None of the goodwill is expected to be deductible for tax purposes. The Company’s goodwill represents the expected profit growth over time that is attributable to expanding our footprint and market share in Singapore and Southeast Asia.
The values assigned to the assets acquired and liabilities assumed are based on the fair value available and may be adjusted during the measurement period of up to 12 months from the date of acquisition as further information becomes available. Any changes in the fair values of the assets acquired and liabilities assumed during the measurement period may result in adjustments to goodwill. The Company incurred transaction costs related to the Singapore Acquisition of $13 that were expensed as part of “Office and general”.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
Below is a summary of the fair value of the net assets acquired on the acquisition date based on external valuations at the date of the Singapore Acquisition.
Fair Value
Assets Acquired:
Cash and cash equivalents
$
491
Accounts receivable
753
Prepaid expenses and other assets
88
Property and equipment
9
Operating lease right-of-use assets
32
Deferred tax assets
766
Intangible assets
212
Goodwill
847
Assets Acquired
$
3,198
Liabilities Assumed:
Accrued expenses and other current liabilities
$
580
Other long-term liabilities
44
Liabilities Assumed
$
624
Fair value of consideration transferred
$
2,574
Intangible assets are amortized on a straight-line basis over their estimated useful lives. The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives on the date of the Singapore Acquisition.
Fair Value
Useful Life
Non-compete agreements
$
28
5 years
Customer lists
97
4 years
Trade name
87
5 years
Total identifiable assets
$
212
NOTE 7 – STOCK-BASED COMPENSATION
Incentive Compensation Plan
The Company maintains the Hudson Global, Inc. 2009 Incentive Stock and Awards Plan, as amended and restated on May 24, 2016 and further amended on September 14, 2020 and May 17, 2022 (the “ISAP”), pursuant to which it can issue equity-based compensation incentives to eligible participants. The ISAP permits the granting of stock options, restricted stock, restricted stock units, and other types of equity-based awards. The Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) will establish such conditions as it deems appropriate on the granting or vesting of stock options, restricted stock, restricted stock units and other types of equity-based awards. As determined by the Compensation Committee, equity awards may also be subject to immediate vesting upon the occurrence of certain events including death, disability, retirement or a change in control of the Company. When we make grants of restricted stock or restricted stock units to our executive officers, including the named executive officers, we enter into Restricted Stock Agreements and Restricted Stock Unit Agreements with such executive officers that contain provisions that are triggered upon a termination of an executive officer or a change in control of our Company. For awards of restricted stock granted beginning on November 6, 2015, effective upon a change in control of our Company, if the executive is employed by us or an affiliate of ours immediately prior to the date of such change in control and is subsequently terminated within 12 months following the date of such change in control, the shares of restricted stock will fully vest and the restrictions imposed upon the restricted stock will be immediately deemed to have lapsed. For awards of restricted stock units granted beginning on March 10, 2016, effective upon a change in control of our Company, if the executive is employed by us or an affiliate of ours immediately prior to the date of such change
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
in control and is subsequently terminated within 12 months following the date of such change in control, the restricted stock units will fully vest and the restrictions imposed upon the restricted stock units will be immediately deemed to have lapsed. The Company primarily grants restricted stock and restricted stock units to its employees. A restricted stock unit is equivalent to one share of the Company’s common stock and is payable only in common stock of the Company issued under the ISAP.
The Compensation Committee administers the ISAP and may designate any of the following as a participant under the ISAP: any officer or other employee of the Company or its affiliates or individuals engaged to become an officer or employee, consultants or other independent contractors who provide services to the Company or its affiliates, and non-employee directors of the Company. On May 17, 2022, the Company’s stockholders at the 2022 Annual Meeting of Stockholders approved amendments to the ISAP to, among other things, increase the number of shares of the Company’s common stock that are reserved for issuance by 250,000 shares. As of September 30, 2024, there were 116,546 shares of the Company’s common stock available for future issuance under the ISAP.
All share issuances related to stock compensation plans are issued from the aforementioned stock available for future issuance under stockholder approved compensation plan.
For the nine months ended September 30, 2024, the Company granted 47,647 restricted stock units subject to performance vesting conditions for the year ended December 31, 2024, and granted 12,540 of discretionary time-vested restricted stock units to certain employees that were not subject to performance conditions. For the nine months ended September 30, 2023, the Company granted 28,841 restricted stock units subject to performance vesting conditions for the year ended December 31, 2023.
A summary of the quantity and vesting conditions for stock-based units granted to the Company’s employees for the nine months ended September 30, 2024 was as follows:
Vesting conditions
Number of Restricted Stock Units Granted
Performance and service conditions - Type 1 (1) (2)
14,939
Performance and service conditions - Type 2 (1) (2)
32,708
Service conditions only - Type 1 (2)
12,540
Total shares of stock award granted
60,187
(1)The performance conditions with respect to restricted stock units may be satisfied as follows:
(a)For grants to Corporate office employees subject to 2024 performance conditions, 100% of the restricted stock units may be earned on the basis of performance as measured by a “group adjusted EBITDA”.
(2)To the extent restricted stock units are earned, such restricted stock units will vest on the basis of service as follows:
(a)33% and 66.6% for Type 1 and Type 2, respectively, of the restricted stock units will vest on the first anniversary of the grant date;
(b)33% and 16.7% for Type 1 and Type 2, respectively, of the restricted stock units will vest on the second anniversary of the grant date; and
(c)34% and 16.7% for Type 1 and Type 2, respectively, of the restricted stock units will vest on the third anniversary of the grant date; provided that, in each case, the employee remains employed by the Company from the grant date through the applicable service vesting date.
The Company also maintains the Director Deferred Share Plan (the “Director Plan”) as part of the ISAP pursuant to which it can issue restricted stock units to its non-employee directors. A restricted stock unit is equivalent to one share of the Company’s common stock and is payable only in common stock issued under the ISAP upon a director ceasing service as a member of the Company’s Board. The restricted stock units vest immediately upon grant and are credited to each of the non-employee director’s retirement accounts under the Director Plan. Restricted stock units issued under the Director Plan contain the right to a dividend equivalent award in the form of additional restricted stock units. The dividend equivalent award is calculated using the same rate as the cash dividend paid on a share of the Company’s common stock, and then divided by the
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
closing price of the Company’s common stock on the date the dividend is paid to determine the number of additional restricted stock units to grant. Dividend equivalent awards have the same vesting terms as the underlying awards. During the nine months ended September 30, 2024, the Company granted 17,540 restricted stock units to its non-employee directors pursuant to the Director Plan.
As of September 30, 2024, 231,406 restricted stock units are deferred under the Company’s ISAP.
For the three and nine months ended September 30, 2024 and 2023, the Company’s stock-based compensation expense related to restricted stock units and restricted shares of common stock were as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
2024
2023
Restricted shares of common stock
$
—
$
—
$
—
$
16
Restricted stock units
481
131
945
971
Restricted stock units-cash settled liabilities
—
—
101
—
Total
$
481
$
131
$
1,046
$
987
Restricted Stock Units
As of September 30, 2024, the Company had $704 of unrecognized stock-based compensation expense related to outstanding unvested restricted stock units. The Company expects to recognize that cost over a weighted average service period of 0.8 years. Restricted stock units have no voting or dividend rights until the awards are vested.
Changes in the Company’s restricted stock units for the nine months ended September 30, 2024 and 2023 were as follows:
Nine Months Ended September 30, 2024
Performance-based
Time-based/Director
Total
Number of Shares of Restricted Stock Units
Weighted Average Grant-Date Fair Value
Number of Shares of Restricted Stock Units
Weighted Average Grant-Date Fair Value
Number of Shares of Restricted Stock Units
Weighted Average Grant-Date Fair Value
Unvested restricted stock units at January 1, 2024
95,264
$
23.49
80,422
$
16.50
175,686
$
20.29
Granted
47,647
$
14.51
30,080
$
17.00
77,727
$
15.47
Vested
(58,051)
$
22.27
(24,723)
$
18.34
(82,774)
$
21.09
Forfeited
(28,841)
$
22.27
(340)
$
17.72
(29,181)
$
22.22
Unvested restricted stock units at September 30, 2024
56,019
$
17.76
85,439
$
16.13
141,458
$
16.78
(a) The number of shares earned above target are based on the performance target established by the Compensation Committee at the initial grant date.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
Nine Months Ended September 30, 2023
Performance-based
Time-based/Director
Total
Number of Shares of Restricted Stock Units
Weighted Average Grant-Date Fair Value
Number of Shares of Restricted Stock Units
Weighted Average Grant-Date Fair Value
Number of Shares of Restricted Stock Units
Weighted Average Grant-Date Fair Value
Unvested restricted stock units at January 1, 2023
130,186
$
23.56
33,390
$
20.31
163,576
$
22.89
Granted
28,841
$
22.27
5,648
$
21.00
34,489
$
22.06
Shares earned above target (a)
3,940
$
35.72
—
$
—
3,940
$
35.72
Vested
(58,834)
$
22.10
(16,291)
$
19.46
(75,125)
$
21.53
Forfeited
(8,869)
$
35.10
(2,380)
$
14.54
(11,249)
$
30.75
Unvested restricted stock units at September 30, 2023
95,264
$
23.49
20,367
$
21.86
115,631
$
23.20
(a) The number of shares earned above target are based on the performance targets established by the Compensation Committee at the initial grant date.
(a) The number of shares earned above target are based on the performance target established by the Compensation Committee at the initial grant date.
Shares of Common Stock
There were no vested or unvested of restricted shares of common stock for nine months ended September 30, 2024. Changes in the Company’s restricted shares of common stock for the nine months ended September 30, 2023 were as follows:
Nine Months Ended September 30,
2023
Number of Restricted Shares of Common Stock
Weighted Average Grant-Date Fair Value
Unvested restricted shares of common stock at January 1
17,410
$
9.57
Vested
(17,410)
$
9.57
Unvested restricted shares of common stock at September 30,
—
$
—
NOTE 8 – INCOME TAXES
Income Tax Provision
Under ASC 270, “Interim Reporting”, and ASC 740-270, “Income Taxes – Interim Reporting”, the Company is required to adjust its effective tax rate for each quarter to be consistent with the estimated annual effective tax rate. Jurisdictions with a projected loss for the full year where no tax benefit can be recognized are excluded from the calculation of the estimated annual effective tax rate. Applying the provisions of ASC 270 and ASC 740-270 could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings versus annual projections.
Effective Tax Rate
The provision for income taxes for the nine months ended September 30, 2024 was $463 on a pre-tax loss of $3,722, compared to a provision for income taxes of $1,148 on pre-tax income of $2,613 for the same period in 2023. The Company’s effective income tax rate ("ETR") was negative 12% and positive 44% for the nine months ended September 30, 2024 and 2023, respectively. For the nine months ended September 30, 2024, the effective tax rates differed from the U.S. Federal statutory rate of 21% primarily due to pretax losses for which no tax benefit can be recognized foreign tax rate differences, and
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
non-deductible expense. For the nine months ended September 30, 2023, the effective tax rates differed from the U.S. Federal statutory rate of 21% primarily due to a discrete tax benefit recognized following the lapse of certain statutes of limitations related to Spain, recognition of a portion of a deferred tax asset in Canada, state income taxes, changes in valuation allowances in the U.S. and certain foreign jurisdictions which reduces or eliminates the effective tax rate on current year profits or losses, foreign tax rate differences, taxes on repatriations or deemed repatriation of foreign profits, and non-deductible expenses. The current YTD ETR differs significantly from the prior period YTD ETR primarily due to the interaction of similar rate reconciliation items, including change in valuation allowance, with a negative pretax book income in the current period versus positive pretax book income in the prior year comparative period.
Uncertain Tax Positions
As of both September 30, 2024 and December 31, 2023, the Company had $60, respectively, of unrecognized tax benefits, excluding interest and penalties, which if recognized in the future, would lower the Company’s effective income tax rate.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as part of the provision for income taxes. As of September 30, 2024 and December 31, 2023, the Company had $31 and $27, respectively, of accrued interest and penalties associated with unrecognized tax benefits.
The statute of limitations for capital gains taxes on the transfer of shares in Spain lapsed in January 2023. The FIN48 reserve for Spain capital gains taxes, interest, and penalties of approximately $408 was released as a tax benefit in the first quarter of 2023.
Based on information available as of September 30, 2024, it is reasonably possible that the total amount of unrecognized tax benefits could decrease by $0 over the next 12 months as a result of projected resolutions of global tax examinations and controversies and potential expirations of the applicable statutes of limitations.
In many cases, the Company’s unrecognized tax benefits are related to tax years that remain subject to examination by the relevant tax authorities. Tax years with net operating losses (“NOLs”) remain open until such losses expire or until the statutes of limitations for those years when the NOLs are used expire. As of September 30, 2024, the Company’s open tax years, which remain subject to examination by the relevant tax authorities, are between 2016 and 2023 depending on the jurisdiction.
The Company believes that its unrecognized tax benefits as of September 30, 2024 are appropriately reflected for all years subject to examination above.
Net Operating Losses (“NOLs”), Capital Losses, and Valuation Allowance
The Company recorded a valuation allowance against all of our consolidated US deferred tax assets for NOLs and Capital Losses as of September 30, 2024 and December 31, 2023. We intend to continue maintaining a full valuation allowance on our deferred tax assets for NOLs until there is sufficient evidence to support the reversal of all or some portion of these allowances in the future.
NOTE 9 – EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per share is computed by dividing the Company’s net income (loss) by the weighted average number of shares outstanding during the period. When the effects are not anti-dilutive, diluted earnings (loss) per share is computed by dividing the Company’s net income (loss) by the weighted average number of shares outstanding and the impact of all dilutive potential common shares, primarily stock options “in-the-money”, unvested restricted stock, and unvested restricted stock units. The dilutive impact of stock options, unvested restricted stock, and unvested restricted stock units is determined by applying the “treasury stock” method. Performance-based restricted stock awards are included in the computation of diluted earnings per share only to the extent that the underlying performance conditions: (i) are satisfied prior to the end of the reporting period; or (ii) would be satisfied if the end of the reporting period were the end of the related performance period and the result would be dilutive under the treasury stock method. Stock awards subject to vesting or exercisability based on the achievement of market conditions are included in the computation of diluted earnings per share only when the market conditions are met.
- 15 -
HUDSON GLOBAL, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
A reconciliation of the numerators and denominators of the basic and diluted earnings (loss) per share calculations for the three and nine months ended September 30, 2024 and 2023 were as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
2024
2023
Earnings (loss) per share (“EPS”):
Basic
$
(0.28)
$
0.17
$
(1.39)
$
0.48
Diluted
$
(0.28)
$
0.17
$
(1.39)
$
0.47
EPS numerator - basic and diluted:
Net (loss) income
$
(846)
$
533
$
(4,185)
$
1,465
EPS denominator (in thousands):
Weighted average common stock outstanding - basic
2,975
3,068
3,009
3,062
Common stock equivalents: restricted stock units and restricted shares of common stock
—
(a)
73
—
(a)
72
Weighted average number of common stock outstanding - diluted
2,975
3,141
3,009
3,134
(a) The diluted weighted average number of shares of common stock outstanding did not differ from the basic weighted average number of shares of common stock outstanding because the effects of any potential common stock equivalents (see Note 7 to the Condensed Consolidated Financial Statements for further details on unvested restricted stock units) were anti-dilutive and therefore not included in the calculation of the denominator of dilutive earnings per share.
The weighted average number of shares outstanding used in the computation of diluted net earnings per share for the three and nine months ended September 30, 2024 and 2023 did not include the effect of the following potentially outstanding shares of common stock because the effect would have been anti-dilutive:
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
2024
2023
Unvested restricted stock units
—
22,540
—
300
Total
—
22,540
—
300
NOTE 10– GOODWILL AND INTANGIBLE ASSETS
Goodwill
The Company recorded goodwill of $847 on October 31, 2023 in connection with the Singapore Acquisition (See Note 6 for further information on the Singapore Acquisition).
For the nine months ended September 30, 2024 and the twelve months ended December 31, 2023, the changes in carrying amount of goodwill were as follows:
Carrying Value
2024
Goodwill, January 1,
$
5,749
Currency translation
22
Goodwill, September 30, 2024
$
5,771
- 16 -
HUDSON GLOBAL, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
Carrying Value
2023
Goodwill, January 1,
$
4,875
Acquisitions
847
Currency translation
27
Goodwill, December 31, 2023
$
5,749
Intangible Assets
The Company’s intangible assets consisted of the following components as of September 30, 2024 and December 31, 2023:
September 30, 2024
Weighted Average Remaining Amortization Useful Lives (in years)
Gross Carrying Amount
Accumulated Amortization
Net Carrying Amount
Non-compete agreements
3.0
$
148
$
(112)
$
36
Trade name
6.2
1,640
(678)
962
Customer lists
2.8
3,960
(2,224)
1,736
Developed technology
0.4
657
(632)
25
$
6,405
$
(3,646)
$
2,759
December 31, 2023
Weighted Average Remaining Amortization Useful Lives (in years)
Gross Carrying Amount
Accumulated Amortization
Net Carrying Amount
Non-compete agreements
3.4
$
147
$
(98)
$
49
Trade name
6.7
1,638
(515)
1,123
Customer lists
3.5
3,957
(1,690)
2,267
Developed technology
0.9
657
(468)
189
$
6,399
$
(2,771)
$
3,628
Amortization expense for the three and nine months ended September 30, 2024 was $293 and $875, respectively. Intangible assets are amortized on a straight-line basis over their estimated useful lives. Noimpairment in the value of amortizable intangible assets was recognized during the nine months ended September 30, 2024 and 2023.
Estimated future amortization expense for intangible assets for the remainder of the fiscal year ending December 31, 2024, and for each of the next fiscal years are as follows:
2024
$
256
2025
872
2026
637
2027
551
2028
130
Thereafter
313
$
2,759
- 17 -
HUDSON GLOBAL, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
The change in the book value of amortizable intangible assets is as follows:
January 1, 2024
Beginning Balance
Amortization
Translation and Other
September 30, 2024
Ending Balance
Non-compete agreements
$
49
$
(14)
$
1
$
36
Trade name
1,123
(163)
2
962
Customer lists
2,267
(534)
3
1,736
Developed technology
189
(164)
—
25
$
3,628
$
(875)
$
6
$
2,759
NOTE 11 – CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023 was as follows:
September 30, 2024
December 31, 2023
Cash and cash equivalents
$
15,835
$
22,611
Restricted cash, current
457
354
Restricted cash, non-current
201
205
Total cash, cash equivalents, and restricted cash
$
16,493
$
23,170
Restricted cash primarily includes lease and collateral deposits, as well as bank guarantees for licensing.
NOTE 12 – COMMITMENTS AND CONTINGENCIES
Litigation and Complaints
The Company is subject, from time to time, to various claims, lawsuits, contracts disputes, and other complaints from, for example, clients, candidates, suppliers, landlords for both leased and subleased properties, former and current employees, and regulators or tax authorities arising in the ordinary course of business. The Company routinely monitors claims such as these, and records provisions for losses when the claim becomes probable and the amount due is estimable. Although the outcome of these claims cannot be determined, the Company believes that the final resolution of these matters will not have a material adverse effect on the Company’s financial condition, results of operations or liquidity.
For matters that reach the threshold of probable and estimable, the Company establishes reserves for legal, regulatory, and other contingent liabilities. The Company did not have any legal reserves as of September 30, 2024 and December 31, 2023.
Operating Leases
Our office space leases have lease terms of one year to four years. Some of these operating leases include options to extend the lease terms, and some operating leases include options to terminate the leases earlier than the expiration of the full terms. These options are considered in our determination of the valuation of our right-of-use assets and lease liabilities.
None of our operating leases include implicit rates, and we have determined that the difference between the contractual cost basis and the present value of lease payments calculated using incremental borrowing rates is not material. Our operating lease costs for the nine months ended September 30, 2024 and 2023 were $1,010 and $877, respectively (reflected in Net cash used in operating activities). The weighted average remaining lease term of our operating leases as of September 30, 2024 was 2.5 years.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
As of September 30, 2024, future minimum operating lease payments are as follows:
2024
2025
2026
2027
2028
2029
Total
Minimum lease payments
$
219
$
648
$
168
$
93
$
95
$
78
$
1,301
Invoice Finance Credit Facility
On April 8, 2019, the Company’s Australian subsidiary (“Australian Borrower”) entered into an invoice finance credit facility agreement (the “NAB Facility Agreement”) with National Australia Bank Limited (“NAB”). The NAB Facility Agreement provides the Australian Borrower with the ability to borrow funds based on a percentage of eligible trade receivables up to a maximum of 4 million Australian dollars. No receivables have terms greater than 90 days, and any risk of loss is retained by the Australian Borrower. The interest rate is calculated as the variable receivable finance indicator rate, plus a margin of 1.60% per annum. Borrowings under this facility are secured by substantially all of the assets of the Australian Borrower. The NAB Facility Agreement does not have a stated maturity date and can be terminated by either the Australian Borrower or NAB upon 90 days written notice. As of September 30, 2024, there were no amounts outstanding under the NAB Facility Agreement. Interest expense and fees incurred on the NAB Facility Agreement were$4 and $13 for the three and nine months ended September 30, 2024, respectively, and $4 and $13 for the three and nine months ended September 30, 2023, respectively.
The NAB Facility Agreement contains various restrictions and covenants for the Australian Borrower including (1) that EBITDA must be at least two times total interest paid on debt on a 12-month rolling basis; (2) minimum tangible net worth must be at least 2.5 million Australian dollars and be equal to at least 25% of total tangible assets on June 30 and December 31 (as defined in the NAB Facility Agreement); and (3) additional periodic reporting requirements to NAB. The Australian Borrower was in compliance with all financial covenants under the NAB Facility Agreement as of September 30, 2024.
Amounts borrowed from the NAB Facility may be large, contain short maturities and have quick turnovers. Amounts borrowed and repaid are presented on a net basis on the Condensed Consolidated Statements of Cash Flows.
On May 25, 2022, Hudson Global Resources (Singapore) Pte. Ltd. (“Singapore Borrower”), which the Company acquired on October 31, 2023 (see Note 5 to the Consolidated Financial Statements in Item 8), and the Hong Kong and Shanghai Banking Corporation Limited (“HSBC”), entered into an invoice finance credit facility agreement (the “HSBC Facility Agreement”). The HSBC Facility Agreement allows the Singapore Borrower to borrow funds up to a maximum of 1 million Singapore dollars, based on a percentage of eligible trade receivables. All receivables have a term of no more than 60 days, and any risk of loss is borne by the Singapore Borrower. The interest rate is calculated as the bank’s external cost of capital, plus a margin of 3.5% per annum. The Company ended the HSBC Facility Agreement in May 2024. Interest expense and fees incurred on the HSBC Facility Agreement were $6 for the nine months ended September 30, 2024.
NOTE 13 – STOCKHOLDERS’ EQUITY
Common Stock
On July 30, 2015, the Company announced that its Board authorized the repurchase of up to $10,000 of the Company’s common stock and this repurchase program was completed in June 2023. On August 8, 2023, the Company’s Board of Directors authorized a new stock repurchase program for up to $5,000 of the Company’s outstanding shares of common stock. The Company has repurchased shares from time to time as market conditions warrant. This authorization does not expire. Under the new stock repurchase program, the Company intends to repurchase shares through open market purchases, privately negotiated transactions, block purchases, or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934 (the “Exchange Act”).
During the nine months ended September 30, 2024 the Company repurchased a total of 154,084 shares of its common stock for a cost of $2,495 under this authorization. Of these shares, 44,250 shares were repurchased on January 29, 2024 in connection with a transaction with a certain shareholder totaling $655 that excludes tax withholdings. The Company also repurchased 69,567 shares during the second quarter in connection with transactions with certain shareholders totaling $1,181, as well as 40,267 shares of its common stock on the open market for a cost of $659. For the nine months ended September 30, 2023, the Company repurchased 36,842 shares of its common stock on the open market for $774. As of September 30, 2024,
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
under the July 30, 2015 and August 8, 2023 authorizations combined, the Company had repurchased an aggregate of 667,496 shares for a total cost of $12,882, completing the July 30, 2015 authorization and leaving $2,119 available for purchase under the August 8, 2023 authorization.
The Company cannot predict when or if it will repurchase any shares of common stock as such stock repurchase program will depend on a number of factors, including constraints specified in any Rule 10b5-1 trading plans, price, general business and market conditions, and alternative investment opportunities. Information regarding share repurchases will be available in the Company’s periodic reports on Form 10-Q and 10-K filed with the Securities and Exchange Commission as required by the applicable rules of the Exchange Act.
NOTE 14 – SHELF REGISTRATION STATEMENT
On June 30, 2022, the Company filed a shelf registration on Form S-3 with the SEC. Under the Form S-3, the Company may offer, issue and sell, from time to time, in one or more offerings and series, together or separately, shares of its common stock, shares of preferred stock, debt securities, subscription rights, purchase contracts, or units, which together shall have an aggregate initial offering price not to exceed $100,000. The registration statement was declared effective by the SEC on July 26, 2022. As of September 30, 2024, no securities had been offered or issued under the registration statement.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
NOTE 15 – SEGMENT AND GEOGRAPHIC DATA
Segment Reporting
The Company operates in three reportable segments: the Hudson regional businesses of Americas, Asia Pacific, and EMEA. Corporate expenses are reported separately for the three reportable segments and pertain to certain functions, such as executive management, corporate governance, investor relations, legal, accounting, tax, and treasury. A portion of these expenses are attributed to the reportable segments for providing the above services to them, and have been allocated to the segments as management service expenses, and are included in the segments’ non-operating other income (expense). Segment information is presented in accordance with ASC 280, “Segment Reporting.”This standard is based on a management approach that requires segmentation based upon the Company’s internal organization and disclosure of revenue and certain expenses based upon internal accounting methods. The Company’s financial reporting systems present various data for management to run the business, including internal profit and loss statements prepared on a basis not consistent with U.S. GAAP. Accounts receivable and long-lived assets are the only significant asset separated by segment for internal reporting purposes.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
Americas
Asia Pacific
EMEA
Corporate
Inter- Segment Elimination
Total
For The Three Months Ended September 30, 2023
Revenue, from external customers
$
7,167
$
26,106
$
6,125
$
—
$
—
$
39,398
Inter-segment revenue
119
—
18
—
(137)
—
Total revenue
$
7,286
$
26,106
$
6,143
$
—
$
(137)
$
39,398
Adjusted net revenue, from external customers (a)
$
6,854
$
8,694
$
3,822
$
—
$
—
$
19,370
Inter-segment adjusted net revenue
119
(109)
(19)
—
9
—
Total adjusted net revenue (a)
$
6,973
$
8,585
$
3,803
$
—
$
9
$
19,370
EBITDA (loss) (b)
$
20
$
1,890
$
(300)
$
(363)
$
—
$
1,247
Depreciation and amortization
(313)
(52)
(7)
(2)
—
(374)
Intercompany (expense) interest income, net
—
(128)
—
128
—
—
Interest (expense) income, net
—
2
—
88
—
90
Provision for income taxes
(44)
(520)
26
108
—
(430)
Net income (loss)
$
(337)
$
1,192
$
(281)
$
(41)
$
—
$
533
For The Nine Months Ended September 30, 2023
Revenue, from external customers
$
25,008
$
81,784
$
20,575
$
—
$
—
$
127,367
Inter-segment revenue
230
—
(6)
—
(224)
—
Total revenue
$
25,238
$
81,784
$
20,569
$
—
$
(224)
$
127,367
Adjusted net revenue, from external customers (a)
$
24,097
$
26,734
$
12,886
$
—
$
—
$
63,717
Inter-segment adjusted net revenue
230
(147)
(66)
—
(17)
—
Total adjusted net revenue
$
24,327
$
26,587
$
12,820
$
—
$
(17)
$
63,717
EBITDA (loss) (b)
$
(876)
$
5,455
$
995
$
(2,169)
$
—
$
3,405
Depreciation and amortization
(936)
(111)
(22)
(7)
—
(1,076)
Intercompany (expense) interest income, net
—
(375)
1,218
375
(1,218)
—
Interest (expense) income, net
—
6
—
278
—
284
(Provision for) benefit from income taxes
111
(1,440)
(387)
568
—
(1,148)
Net income (loss)
$
(1,701)
$
3,535
$
1,804
$
(955)
$
(1,218)
$
1,465
As of December 31, 2023
Accounts receivable, net
$
5,502
$
9,280
$
4,928
$
—
$
—
$
19,710
Long-lived assets, net of accumulated depreciation and amortization (c)
$
7,773
$
1,954
$
33
$
38
$
—
$
9,798
Total assets
$
17,632
$
23,604
$
11,064
$
8,658
$
—
$
60,958
(a)Adjusted net revenue is net of the Direct contracting costs and reimbursed expenses caption on the Condensed Consolidated Statements of Operations. Direct contracting costs and reimbursed expenses include the direct staffing costs of salaries, payroll taxes, employee benefits, travel expenses, and insurance costs for the Company’s contractors and reimbursed out-of-pocket expenses and other direct costs. The region where services are provided, the mix of RPO and contracting, and the functional nature of the staffing services provided can affect operating income and EBITDA. The salaries, commissions, payroll taxes, and employee benefits related to recruitment professionals are included under the caption “Salaries and related” in the Condensed Consolidated Statements of Operations.
(b)SEC Regulation S-K Item 229.10(e)1(ii)(A) defines EBITDA as earnings before interest, taxes, depreciation and amortization. EBITDA is presented to provide additional information to investors about the Company’s operations on a basis consistent with the measures that the Company uses to manage its operations and evaluate its performance.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
Management also uses this measurement to evaluate working capital requirements. EBITDA should not be considered in isolation or as a substitute for operating income and net income prepared in accordance with U.S. GAAP or as a measure of the Company’s profitability.
(c)Comprised of property and equipment, intangible assets and goodwill, net of accumulated depreciation and amortization.
Geographic Data Reporting
A summary of revenues for the three and nine months ended September 30, 2024 and 2023 and net assets by geographic area as of September 30, 2024 and 2023 and as of December 31, 2023, were as follows:
Australia
United States
United Kingdom
Other
Total
For The Three Months Ended September 30, 2024
Revenue (a)
$
18,089
$
7,233
$
5,913
$
5,618
$
36,853
For The Three Months Ended September 30, 2023
Revenue (a)
$
23,620
$
6,706
$
5,807
$
3,265
$
39,398
For The Nine Months Ended September 30, 2024
Revenue (a)
$
54,770
$
19,577
$
17,317
$
14,792
$
106,456
For The Nine Months Ended September 30, 2023
Revenue (a)
$
73,414
$
23,501
$
19,503
$
10,949
$
127,367
As of September 30, 2024
Long-lived assets, net of accumulated depreciation and amortization (b)
$
28
$
6,938
$
17
$
1,848
$
8,831
Net assets
$
8,195
$
17,670
$
4,271
$
12,804
$
42,940
As of December 31, 2023
Long-lived assets, net of accumulated depreciation and amortization (b)
$
49
$
7,811
$
33
$
1,905
$
9,798
Net assets
$
9,634
$
22,585
$
5,084
$
11,251
$
48,554
(a) Revenue by geographic region disclosed above is net of any inter-segment revenue and, therefore, represents only revenue from external customers according to the location of the operating subsidiary.
(b) Comprised of property and equipment, intangible assets and goodwill, net of accumulated depreciation and amortization.
NOTE 16 – STOCKHOLDER RIGHTS PLAN
On October 15, 2018, the Company’s Board of Directors declared a dividend to the Company’s stockholders of record as of the close of business on October 25, 2018 (the “Record Date”), for each outstanding share of the Company’s common stock, of one right (a “Right”) to purchase one one-hundredth of a share of a new series of participating preferred stock of the Company. The terms of the Rights are set forth in the Rights Agreement, dated as of October 15, 2018 (as amended, the “Rights Agreement”), by and between the Company and Computershare Trust Company, N.A., as rights agent (the “Rights Agent”). The Company’s stockholders approved the Rights Agreement at the Company’s 2019 Annual Meeting of Stockholders held on May 6, 2019. On September 28, 2021, the Company and the Rights Agent entered into a First Amendment to Rights Agreement (the “Amendment”) that amended the Rights Agreement to extend its term through October 15, 2024. The amendment was approved by the Board on September 28, 2021, subject to stockholder approval, and the Company’s stockholders approved the Amendment at the Company’s 2022 Annual Meeting of Stockholders held on May 17, 2022. The Board of Directors has taken further action to amend the Original Rights Agreement, as amended by the First Amendment, to extend the expiration of the Rights Agreement to October 15, 2027, as contemplated in the Second Amendment to Rights Agreement (the “Second Amendment”). The Second Amendment was approved by the Board on June 13, 2024, subject to stockholder approval, and the
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
Company’s stockholders approved the Amendment at the Company’s 2024 Annual Meeting of Stockholders held on July 31, 2024.
Each Right allows its holder to purchase from the Company one one-hundredth of a share of the Company’s Series B Junior Participating Preferred Stock (“Series B Preferred Stock”) for a purchase price of $3.50. Each fractional share of Series B Preferred Stock would give the stockholder approximately the same dividend, voting and liquidation rights as does one share of common stock. Prior to exercise, however, a Right does not give its holder any dividend, voting or liquidation rights.
The Board entered into the Rights Agreement in an effort to preserve the value of the Company’s significant U.S. NOLs and other tax benefits. The Company’s ability to utilize its NOLs may be substantially limited if the Company experiences an “ownership change” within the meaning of Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”). In general, an “ownership change” would occur if the percentage of the Company’s ownership by one or more “5-percent shareholders” (as defined in the Code) increases by more than 50 percent over the lowest percentage owned by such stockholders at any time during the prior three years. The Rights Agreement is designed to preserve the Company’s tax benefits by deterring transfers of common stock that could result in an “ownership change” under Section 382 of the Code. In general terms, the Rights Agreement imposes a significant penalty upon any person or group that acquires beneficial ownership (as defined under the Rights Agreement) of 4.99% or more of the outstanding common stock without the prior approval of the Board (an “Acquiring Person”). Any Rights held by an Acquiring Person are void and may not be exercised.
The Company also has a provision in its Amended and Restated Certificate of Incorporation (the “Charter Provision”) which generally prohibits transfers of its common stock that could result in an ownership change.
The Rights will not be exercisable until the earlier of (i) 10 days after a public announcement by the Company that a person or group has become an Acquiring Person; and (ii) 10 business days (or a later date determined by the Board) after a person or group begins a tender or an exchange offer that, if completed, would result in that person or group becoming an Acquiring Person.
Until the date that the Rights become exercisable (the “Distribution Date”), common stock certificates will also evidence the Rights and will contain a notation to that effect. Any transfer of shares of common stock prior to the Distribution Date will constitute a transfer of the associated Rights. After the Distribution Date, the Rights will separate from the common stock and be evidenced by Right certificates, which the Company will mail to all holders of Rights that have not become void. After the Distribution Date, if a person or group already is or becomes an Acquiring Person, all holders of Rights, except the Acquiring Person, may exercise their Rights upon payment of the purchase price to purchase shares of common stock (or other securities or assets as determined by the Board) with a market value of two times the purchase price (a “Flip-in Event”). After the Distribution Date, if a Flip-in Event has already occurred and the Company is acquired in a merger or similar transaction, all holders of Rights, except the Acquiring Person, may exercise their Rights upon payment of the purchase price, to purchase shares of the acquiring or other appropriate entity with a market value of two times the purchase price of the Rights. Rights may be exercised to purchase Series B Preferred Stock only after the Distribution Date occurs and prior to the occurrence of a Flip-in Event as described above. A Distribution Date resulting from the commencement of a tender offer or an exchange offer as described in the second bullet point above could precede the occurrence of a Flip-in Event, in which case the Rights could be exercised to purchase Series B Preferred Stock. A Distribution Date resulting from any occurrence described in the first bullet point above would necessarily follow the occurrence of a Flip-in Event, in which case the Rights could be exercised to purchase shares of common stock (or other securities or assets) as described above.
The Rights will expire on the earliest of (i) the Close of Business on October 15, 2027, or such earlier date as of which the Board determines that this Agreement is no longer necessary for the preservation of Tax Benefits, (ii) the time at which the Rights are redeemed as provided in Section 23, (iii) the time at which all exercisable Rights are exchanged as provided in Section 24, (iv) the Close of Business on the effective date of the repeal of Section 382 of the Code or any successor or replacement provision if the Board determines that this Agreement is no longer necessary for the preservation of Tax Benefits, and (v) the Close of Business on the first day of a taxable year of the Company to which the Board determines that no Tax Benefits may be carried forward.
The Board may redeem all (but not less than all) of the Rights for a redemption price of $0.001 per Right at any time before the later of the Distribution Date and the date of the first public announcement or disclosure by the Company that a person or group has become an Acquiring Person. Once the Rights are redeemed, the right to exercise the Rights will terminate, and the only right of the holders of such Rights will be to receive the redemption price.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
The Board may adjust the purchase price of the Series B Preferred Stock, the number of shares of Series B Preferred Stock issuable and the number of outstanding Rights to prevent dilution that may occur as a result of certain events, including, among others, a stock dividend, a stock split or a reclassification of the Series B Preferred Stock or common stock.
Before the time the Rights cease to be redeemable, the Board may amend or supplement the Rights Agreement without the consent of the holders of the Rights, except that no amendment may decrease the redemption price below $0.001 per Right.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the Condensed Consolidated Financial Statements and the notes thereto, included in Part I of this Form 10-Q. The reader should also refer to the Condensed Consolidated Financial Statements and notes of Hudson Global, Inc. and its subsidiaries (the “Company”) filed in its Annual Report on Form 10-K for the year ended December 31, 2023. This MD&A contains forward-looking statements. Please see “FORWARD-LOOKING STATEMENTS” for a discussion of the uncertainties, risks and assumptions associated with these statements. This MD&A also uses the non-generally accepted accounting principle measure of earnings before interest, taxes, depreciation and amortization (“EBITDA”). See Note 15 to the Condensed Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q for EBITDA segment reconciliation information. The tables and information in this MD&A were derived from exact numbers and may have immaterial rounding differences.
This MD&A includes the following sections:
•Executive Overview
•Results of Operations
•Liquidity and Capital Resources
•Contingencies
•Recent Accounting Pronouncements
•Critical Accounting Estimates
•Forward-Looking Statements
Executive Overview
The Company’s objective is to increase value to the Company’s stockholders by providing global Recruitment Process Outsourcing (“RPO”) solutions to customers. With direct operations in fourteen countries and relationships with specialized professionals and organizations around the globe, the Company brings a strong ability to match talent with opportunities by assessing, recruiting, developing, and engaging highly successful people for the Company’s clients. The Company combines broad geographic presence, world-class talent solutions and a tailored, consultative approach to help businesses and professionals achieve maximum performance. The Company seeks to continually upgrade its service offerings and delivery capability tools to make the Company and candidates more successful in achieving clients’ business requirements.
The Company’s proprietary frameworks, assessment tools, and leadership development programs, coupled with its global footprint, allow the Company to design and implement regional and global outsourced recruitment solutions that the Company believes greatly enhance the quality and efficiency of its clients’ hiring.
To meet the Company’s objective, the Company engages in the following initiatives:
•Facilitating growth and development of the global RPO business through strategic investments in people, innovation, and technology;
•Building and differentiating the Company’s brand through its unique outsourcing solutions offerings; and
•Improving the Company’s cost structure and efficiency of its support functions and infrastructure.
We continue to explore all strategic alternatives to maximize value for the Company’s stockholders, including without limitation, improving the market position and profitability of our services in the marketplace, and enhancing our valuation. We may pursue our goals through organic growth, strategic initiatives, or other alternatives. Additionally, we will continue to monitor capital markets for opportunities to repurchase shares, and consider other actions designed to enhance value to our stockholders, as well as review information regarding potential acquisitions or combinations, both within the RPO business line as well as other businesses, and provide information to third parties regarding potential dispositions of assets or business lines, from time to time.
This MD&A discusses the results of the Company’s business for the three and nine months ended September 30, 2024 and 2023.
Current Market Conditions
Our clients’ demands for RPO and contracting services largely depend on the market conditions and the strength of the labor markets in the countries where we operate. In the third quarter of 2024, the market conditions remained challenging due to persistent inflation, higher interest rates, and decreased demand for labor in certain markets. We anticipate that these challenging market conditions will continue into the final quarter of 2024.
Economic conditions in most of the world’s major markets continued to slow down throughout 2023 and into the third quarter of 2024. Higher than expected inflation in most markets and rising interest rates have led to significant market disruption, including further wage inflation, increased operating costs, staffing challenges, reduced consumer confidence, and limited capital market accessibility that impact our business. In addition, in connection with the challenging business environment, some of our customers have reduced demand, and certain other customers have eliminated our services on a temporary or permanent basis. These conditions and expected future inflation and potential interest rate increases could have material adverse impacts on various aspects of our business in the future.
The continued economic uncertainty has also resulted in volatility in global currencies. Stronger foreign currencies in other markets compared to the U.S. dollar during a reporting period cause local currency results of the Company’s foreign operations to be translated into more U.S. dollars.
The following is a summary of the Company’s financial performance highlights for the three and nine months ended September 30, 2024 and 2023. This summary should be considered in the context of the additional disclosures in this MD&A which further highlight Companyresults by segment.
Summary of Financial Performance Highlights for the Three Months Ended September 30, 2024
•Revenue was $36.9 million for the three months ended September 30, 2024, compared to $39.4 million for the same period in 2023, a decrease of $2.5 million, or 6.5%.The decrease in revenue was principally driven by declines in Australia.
◦On a constant currency basis, the Company’s revenue decreased $3.2 million, or 8.1%, primarily due to declines in contracting revenue of $1.7 million, or 8.0%, and in RPO revenue of $1.5 million, or 8.1%, compared to the same period in 2023.
•Adjusted net revenue was $18.6 million for the three months ended September 30, 2024, compared to $19.4 million for the same period in 2023, a decrease of $0.8 million, or 4.0%.
◦On a constant currency basis, adjusted net revenue decreased $1.0 million, or 5.2%, due to a decrease in RPO adjusted net revenue of $1.1 million, or 5.9%, partially offset by an increase in contracting adjusted net revenue of $0.1 million, or 7.0%, compared to the same period in 2023.
•Selling, general and administrative expenses (including salaries and related expenses) and other non-operating income (expense) (“SG&A and Non-Op”) was $18.9 million for the three months ended September 30, 2024, compared to $18.1 million for the same period in 2023, an increase of $0.8 million, or 4.2%.
◦On a constant currency basis, SG&A and Non-Op increased $0.5 million, or 3.0%, as compared to the same period in 2023. SG&A and Non-Op as a percentage of revenue was 51.2% for the three months ended September 30, 2024, compared to 45.8% for the same period in 2023.
•EBITDA loss was $0.3 million for the three months ended September 30, 2024, compared to EBITDA of $1.2 million for the same period in 2023, a decrease in EBITDA of $1.5 million. On a constant currency basis, EBITDA decreased $1.6 million.
•Net loss was $0.8 million for the three months ended September 30, 2024, compared to net income of $0.5 million for the same period in 2023, a decrease in net income of $1.4 million. On a constant currency basis, net income also decreased $1.4 million.
Summary of Financial Performance Highlights for the Nine Months Ended September 30, 2024
•Revenue was $106.5 million for the nine months ended September 30, 2024, compared to $127.4 million for the same period in 2023, a decrease of $20.9 million, or 16.4%. The decrease in revenue was principally driven by a decline in Australia.
◦On a constant currency basis, the Company’s revenue decreased $20.6 million, or 16.2%, due to a decrease in RPO revenue of $11.2 million, or 18.0%, coupled with a decrease in contracting revenue of $9.4 million, or 14.6%, compared to the same period in 2023.
•Adjusted net revenue was $52.5 million for the nine months ended September 30, 2024, compared to $63.7 million for the same period in 2023, a decrease of $11.2 million, or 17.5%.
◦On a constant currency basis, adjusted net revenue decreased $11.2 million, or 17.6%, due to a decrease in RPO adjusted net revenue of $10.9 million, or 17.9%, while contracting revenue decreased by $0.4 million, or 12.1%, compared to the same period in 2023.
•SG&A and Non-Op was $55.5 million for the nine months ended September 30, 2024, compared to $60.3 million for the same period in 2023, a decrease of $4.8 million, or 8.0%.
◦On a constant currency basis, SG&A and Non-Op decreased $4.8 million, or 8.0%, as compared to the same period in 2023. SG&A and Non-Op as a percentage of revenue was 52.1% for the nine months ended September 30, 2024, compared to 47.5% for the same period in 2023.
•EBITDA loss was $3.0 million for the nine months ended September 30, 2024, compared to EBITDA of $3.4 million for the same period in 2023, a decrease in EBITDA of $6.4 million. On a constant currency basis, EBITDA also decreased $6.4 million.
•Net loss was $4.2 million for the nine months ended September 30, 2024, compared to net income of $1.5 million for the same period in 2023, a decrease in net income of $5.7 million. On a constant currency basis, net income also decreased $5.7 million.
Constant Currency (Non-GAAP Financial Measure)
The Company operates on a global basis, with the majority of its revenue generated outside of the U.S. Accordingly, fluctuations in foreign currency exchange rates can affect the Company’s results of operations. For the discussion of reportable segment results of operations, the Company uses constant currency information. Constant currency compares financial results between periods as if exchange rates had remained constant period-over-period. The Company defines the term “constant currency” to mean that financial data for a previously reported period is translated into U.S. dollars using the same foreign currency exchange rates that were used to translate financial data for the current period. Constant currency metrics should not be considered in isolation or as a substitute for reported results prepared in accordance with generally accepted accounting principles (“GAAP”) in the U.S. The Company’s management reviews and analyzes business results in constant currency and believes these results better represent the Company’s underlying business trends. Changes in foreign currency exchange rates generally impact only reported earnings.
Changes in revenue, adjusted net revenue, SG&A and Non-Op, operating income (loss), net income (loss), and EBITDA (loss) include the effect of changes in foreign currency exchange rates. The tables below summarize the impact of foreign currency exchange adjustments on the Company’s operating results for the three and nine months ended September 30, 2024 and 2023.
(a)Represents Revenue less the Direct contracting costs and reimbursed expenses caption on the Condensed Consolidated Statements of Operations.
(b)SG&A and Non-Op is a measure that management uses to evaluate the segments’ expenses, which include the following captions on the Condensed Consolidated Statements of Operations: Salaries and related, Office and general, Marketing and promotion, and Other expense, net. Corporate management service allocations are included in the segments’ other income (expense).
(c)See EBITDA reconciliation in the following section.
Use of EBITDA (Non-GAAP Financial Measure)
Management believes EBITDA is a meaningful indicator of the Company’s performance that provides useful information to investors regarding the Company’s financial condition and results of operations. Management considers EBITDA to be the best indicator of operating performance and most comparable measure across the regions in which the Company operates. Management uses this measure to evaluate capital needs and working capital requirements. EBITDA should not be considered in isolation or as a substitute for operating income, or net income prepared in accordance with U.S. GAAP or as a measure of the Company’s profitability. EBITDA is derived from net income adjusted for the provision for (benefit from) income taxes, interest expense (income), and depreciation and amortization.
For the three months ended September 30, 2024, contracting revenue increased by $1.5 million, or 714%, while RPO revenue decreased by $1.1 million, or 16%, compared to the same period in 2023. The increase in contracting revenue was driven by new client wins, while the decline in RPO revenue reflected lower demand from existing clients.
For the nine months ended September 30, 2024, RPO revenue decreased by $5.7 million, or 24%, while contracting revenue increased by $1.3 million, or 162%, as compared to the same period in 2023. The changes in both RPO and contracting revenue were due to lower demand from existing clients.
Adjusted Net Revenue - Americas
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
Change in amount
Change in %
2024
2023
Change in amount
Change in %
$ in millions
As reported
As reported
As reported
As reported
Americas
Adjusted net revenue
$
6.6
$
6.9
$
(0.2)
(3)
%
$
18.8
$
24.1
$
(5.3)
(22)
%
Adjusted net revenue as a percentage of revenue
88
%
96
%
N/A
N/A
91
%
96
%
N/A
N/A
For the three months ended September 30, 2024, RPO adjusted net revenue decreased by $0.5 million, or 8%, while contracting adjusted net revenue increased by $0.3 million, or 967%. The decrease in RPO adjusted net revenue was due to lower demand from existing clients, while the increase in contracting adjusted net revenue was due to new client wins. For the nine months ended September 30, 2024, RPO adjusted net revenue decreased by $5.6 million, or 23%, reflecting the lower demand from existing clients.
For the three months ended September 30, 2024 and 2023, total adjusted net revenue as a percentage of revenue was 88%, compared to 96% for the same period in 2023. The decrease in total adjusted net revenue as a percentage of revenue was attributed to the lower mix of RPO to contracting revenue.
For the nine months ended September 30, 2024, total adjusted net revenue as a percentage of revenue was 91%, compared to 96% for the same period in 2023. The decrease in total adjusted net revenue as a percentage of revenue was due to the same factor noted above.
For the three months ended September 30, 2024, SG&A and Non-Op decreased $0.6 million, or 9%, compared to the same period in 2023, while SG&A and Non-Op as a percentage of revenue decreased from 97% to 83%. The decrease in SG&A and No-Op was principally due to lower staff costs. The decrease in SG&A and Non-Op as a percentage of revenue was primarily due to the decline in staff costs as a percentage of adjusted net revenue.
For the nine months ended September 30, 2024, SG&A and Non-Op decreased $6.2 million, or 24%, compared to the same period in 2023, while SG&A and Non-Op as a percentage of revenue decreased from 101% to 93%. The decrease in SG&A and No-Op was principally due to lower staff costs and overhead costs. The decrease in SG&A and Non-Op as a percentage of revenue was primarily due to the decline in staff costs and overhead costs as a percentage of adjusted net revenue.
Operating (Loss) Income and EBITDA -Americas
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
Change in amount
Change in %
2024
2023
Change in amount
Change in %
$ in millions
As reported
As reported
As reported
As reported
Americas
Operating income (loss)
$
0.2
$
(0.2)
$
0.4
214
%
$
(0.7)
$
(1.4)
$
0.7
51
%
EBITDA (loss)
$
0.4
$
—
$
0.3
N/M
$
(0.1)
$
(0.9)
$
0.8
87
%
EBITDA (loss) as a percentage of revenue
5
%
—
%
N/A
N/A
(1)
%
(4)
%
N/A
N/A
For the three months ended September 30, 2024, operating income was $0.2 million, compared to operating loss of $0.2 million in 2023, and EBITDA was $0.4 million, compared to EBITDA of $0.0 million in 2023.
For the nine months ended September 30, 2024, operating loss was $0.7 million, compared to operating loss of $1.4 million in 2023, and EBITDA loss was $0.1 million, compared to EBITDA loss of $0.9 million in 2023.
The increases in operating income and EBITDA for the three and nine months ended September 30, 2024, were due to the same factors noted above.
For the three months ended September 30, 2024, contracting revenue decreased by $3.3 million, or 18%, while RPO revenue decreased $0.8 million, or 9%, compared to 2023, as discussed below.
In Australia, revenue decreased $6.1 million, or 25%, for the three months ended September 30, 2024, compared to the same period in 2023. The decrease was primarily driven by contracting revenue which declined by $3.6 million, or 21% driven by reduced demand from existing clients. RPO revenue declined by $2.4 million, or 35%, compared to 2023, also due to lower demand from existing clients.
In Asia, revenue increased $1.9 million, or 86%, for the three months ended September 30, 2024, compared to the same period in 2023. The increase in revenue was primarily driven by the acquisition of Hudson Global Resources (Singapore) Pte. Ltd. (“Singapore Acquisition”) (see Note 5 to the Condensed Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q), which contributed 83 percentage points to the revenue growth.
For the nine months ended September 30, 2024, contracting revenue decreased by $10.2 million, or 18%, while RPO revenue decreased by $4.1 million, or 17%, as discussed below.
In Australia, revenue decreased $17.9 million, or 25%, for the nine months ended September 30, 2024, compared to the same period in 2023. The decrease was primarily in contracting revenue, which decreased by $10.4 million, or 20%, while RPO revenue decreased by $7.5 million, or 37%, compared to 2023. The decreases in contracting and recruitment revenue were primarily due to lower demand from existing clients.
In Asia, revenue increased $3.8 million or 51%, for the nine months ended September 30, 2024, compared to 2023. The increase in revenue was primarily driven by the Singapore Acquisition, which contributed 57 percentage points to the revenue growth.
Adjusted net revenue - Asia Pacific
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
Change in amount
Change in %
2024
2023
Change in amount
Change in %
$ in millions
As reported
Constant currency
As reported
Constant currency
Asia Pacific
Adjusted net revenue
$
7.8
$
8.9
$
(1.0)
(11)
%
$
22.0
$
26.5
$
(4.5)
(17)
%
Adjusted net revenue as a percentage of revenue
35
%
33
%
N/A
N/A
33
%
33
%
N/A
N/A
For the three months ended September 30, 2024, RPO adjusted net revenue declined by $0.7 million, or 9%, while contracting adjusted net revenue decreased $0.3 million or 32%, compared to the same period in 2023.
In Australia, adjusted net revenue decreased by $2.6 million, or 35%, for the three months ended September 30, 2024, compared to the same period in 2023. The decrease was primarily reflected in RPO adjusted net revenue, which declined $2.4 million, or 36%, while contracting adjusted net revenue decreased by $0.2 million, or 27% compared to 2023.
In Asia, adjusted net revenue increased by $1.6 million, or 127%, for the three months ended September 30, 2024, compared to the same period in 2023. The increase in adjusted net revenue was primarily driven by the acquisition of Hudson
Global Resources (Singapore) Pte. Ltd. (“Singapore Acquisition”) (see Note 5 to the Condensed Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q), which contributed 125 percentage points to the adjusted net revenue growth.
Total adjusted net revenue as a percentage of revenue was 35% for the three months ended September 30, 2024, compared to 33% for the same period in 2023. The increase in total adjusted net revenue as a percentage of revenue was attributed to a greater mix of higher margin RPO revenue to contracting revenue.
For the nine months ended September 30, 2024, RPO adjusted net revenue decreased by $3.7 million, or 16%, while contracting adjusted net revenue decreased by $0.7 million or by 28%, compared to the same period in 2023.
In Australia, adjusted net revenue decreased by $7.7 million, or 35%, for the nine months ended September 30, 2024, compared to the same period in 2023. The decrease was primarily reflected in RPO adjusted net revenue, which declined by $7.1 million, or 36%, while contracting adjusted net revenue decreased by $0.6 million, or 25%, compared to 2023.
In Asia, adjusted net revenue increased by $3.2 million, or 72%, for the nine months ended September 30, 2024, compared to the same period in 2023. The increase in adjusted net revenue was primarily driven by the Singapore Acquisition, which contributed 80 percentage points to the revenue growth.
Total adjusted net revenue as a percentage of revenue was 33% for each of the nine months ended September 30, 2024 and 2023.
SG&A and Non-Op - Asia Pacific
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
Change in amount
Change in %
2024
2023
Change in amount
Change in %
$ in millions
As reported
Constant currency
As reported
Constant currency
Asia Pacific
SG&A and Non-Op
$
7.5
$
6.8
$
0.7
10
%
$
21.9
$
20.9
$
1.0
5
%
SG&A and Non-Op as a percentage of revenue
33
%
26
%
N/A
N/A
33
%
26
%
N/A
N/A
For the three and nine months ended September 30, 2024, SG&A and Non-Op increased $0.7 million, or 10%, and $1.0 million, or 5%, respectively, compared to the same periods in 2023. The increase in SG&A and Non-Op was primarily due to the Singapore Acquisition.
For each of the three and nine months ended September 30, 2024, SG&A and Non-Op as a percentage of revenue was 33%, as compared to 26% for the same periods in 2023. For the three and nine months ended September 30, 2024, the increase in SG&A and Non-Op as a percentage of revenue was principally due to the Singapore Acquisition.
Operating Income and EBITDA - Asia Pacific
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
Change in amount
Change in %
2024
2023
Change in amount
Change in %
$ in millions
As reported
Constant currency
As reported
Constant currency
Asia Pacific
Operating income
$
0.5
$
2.3
$
(1.8)
(79)
%
$
0.4
$
6.3
$
(5.9)
(93)
%
EBITDA (loss)
$
0.3
$
1.9
$
(1.6)
(84)
%
$
(0.1)
$
5.4
$
(5.5)
(101)
%
EBITDA (loss) as a percentage of revenue
1
%
7
%
N/A
N/A
—
%
7
%
N/A
N/A
For the three months ended September 30, 2024, operating income was $0.5 million, compared to operating income of $2.3 million in 2023, and EBITDA was $0.3 million, or 1% of revenue, compared to EBITDA of $1.9 million, or 7% of revenue, in 2023. The decreases in operating income and EBITDA were principally due to the decline in adjusted net revenue, as described above.
For the nine months ended September 30, 2024, operating income was $0.4 million, compared to operating income of $6.3 million in 2023, and EBITDA loss was $0.1 million, or 0% of revenue, compared to EBITDA of $5.4 million, or 7% of revenue, in 2023. The decreases in operating income and EBITDA were principally due to the decline in adjusted net revenue, as described above.
Europe, Middle East, and Africa ("EMEA")(constant currency)
Revenue - EMEA
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
Change in amount
Change in %
2024
2023
Change in amount
Change in %
$ in millions
As reported
Constant currency
As reported
Constant currency
EMEA
Revenue
$
6.7
$
6.3
$
0.4
7
%
$
19.2
$
21.1
$
(1.9)
(9)
%
For the three months ended September 30, 2024, RPO revenue increased by $0.3 million or 7%, while contracting revenue increased by $0.2 million or 7%, compared to the same period in 2023, as further discussed below.
In the U.K., for the three months ended September 30, 2024, revenue decreased slightly, or 1%. The change was driven by a decrease in RPO revenue of $0.2 million, or 5%, due to lower demand from existing clients, which was mainly offset by an increase in contracting revenue of $0.2 million, or 7%, compared to the same period in 2023.
In Continental Europe, total revenue was $0.7 million for the three months ended September 30, 2024, an increase of $0.3 million, or 103% compared to 2023. The increase was primarily due to new client wins.
In the Middle East, total revenue and RPO revenue was $0.1 million for the three months ended September 30, 2024.
For the nine months ended September 30, 2024, RPO revenue decreased by $1.4 million, or 10%, while contracting revenue decreased by $0.5 million, or 7%, compared to the same period in 2023.
In the U.K., for the nine months ended September 30, 2024 revenue decreased by $2.7 million, or 13%, compared to the same period in 2023. The decrease was driven by RPO revenue, which declined $2.2 million, or 18%, while contracting revenue decreased by $0.5 million, or 7%.
In Continental Europe, total revenue was $1.7 million for the nine months ended September 30, 2024, an increase of $0.7 million, or 61%, compared to the same period in 2023. The increase was primarily due to new client wins.
In the Middle East, total revenue and RPO revenue was $0.1 million for the nine months ended September 30, 2024.
Adjusted Net Revenue - EMEA
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
Change in amount
Change in %
2024
2023
Change in amount
Change in %
$ in millions
As reported
Constant currency
As reported
Constant currency
EMEA
Adjusted net revenue
$
4.1
$
3.9
$
0.2
5
%
$
11.7
$
13.2
$
(1.4)
(11)
%
Adjusted net revenue as a percentage of revenue
61
%
62
%
N/A
N/A
61
%
63
%
N/A
N/A
For the three months ended September 30, 2024, adjusted net revenue increased by $0.2 million, or 5%, primarily driven by an increase in RPO adjusted net revenue of $0.2 million, or 4%, while contracting adjusted net revenue increased slightly, or 63%, compared to the same period in 2023, as further discussed below.
In the U.K., total adjusted net revenue for the three months ended September 30, 2024 decreased by $0.3 million, or 8%, compared to 2023. The decrease was driven by RPO adjusted net revenue, which declined by $0.3 million, or 9%, compared to 2023.
In Continental Europe, total adjusted net revenue was $0.6 million for the three months ended September 30, 2024, an increase of $0.3 million, or 112% compared to 2023. The increase was primarily due to new client wins.
In the Middle East, total adjusted net revenue and RPO adjusted net revenue was $0.1 million for the three months ended September 30, 2024.
For the nine months ended September 30, 2024, adjusted net revenue decreased by $1.4 million, or 11%, driven by a decrease in RPO revenue, which declined $1.5 million, or 12%, compared to the same period in 2023.
In the U.K., total adjusted net revenue for the nine months ended September 30, 2024 decreased by $2.3 million, or 18%, compared to the same period in 2023, driven by a decrease in RPO adjusted net revenue of $2.3 million, or 20%.
In Continental Europe, for the nine months ended September 30, 2024, total adjusted net revenue increased by $0.7 million, or 65%, compared to the same period in 2023, due to new client wins.
In the Middle East, total adjusted net revenue and RPO adjusted net revenue was $0.1 million for the nine months ended September 30, 2024.
SG&A and Non-Op - EMEA
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
Change in amount
Change in %
2024
2023
Change in amount
Change in %
$ in millions
As reported
Constant currency
As reported
Constant currency
EMEA
SG&A and Non-Op
$
4.1
$
4.2
$
(0.1)
(3)
%
$
11.3
$
12.1
$
(0.8)
(7)
%
SG&A and Non-Op as a percentage of revenue
61
%
67
%
N/A
N/A
59
%
58
%
N/A
N/A
For the three months ended September 30, 2024, SG&A and Non-Op decreased $0.1 million, or 3%, compared to the same period in 2023. The decrease in SG&A and Non-Op was primarily the result of lower consultant staff costs in the current year.
For the nine months ended September 30, 2024, SG&A and Non-Op decreased $0.8 million, or 7%, compared to the same period in 2023. The decrease in SG&A and Non-Op was primarily the result of lower consultant staff costs in the current year.
For the three months ended September 30, 2024, SG&A and Non-Op as a percentage of revenue was 61%, compared to 67%, respectively, in 2023. The decrease in SG&A and Non-Op as a percentage of revenue was primarily due to the revenue increase.
For the nine months ended September 30, 2024, SG&A and Non-Op as a percentage of revenue was 59%, compared to 58%, in 2023. The increase in SG&A and Non-Op as a percentage of revenue was primarily due to the revenue decline outpacing the decrease in SG&A and Non-op.
For the three months ended September 30, 2024, operating income was $0.1 million, compared to operating income of $0.2 million for the same period in 2023, and EBITDA was up slightly, or 1% of revenue, compared to EBITDA loss of $0.3 million, or 5% of revenue, for the same period in 2023.
For the nine months ended September 30, 2024, operating income was $0.6 million, compared to operating income of $1.5 million for the same period in 2023, and EBITDA was $0.5 million, or 2% of revenue, compared to EBITDA of $1.0 million, or 5% of revenue, for the same period in 2023.
The following are discussed in reported currency
Corporate Expenses, Net of Corporate Management Expense Allocations
Corporate expenses were $1.0 million for the three months ended September 30, 2024 as compared to $0.4 million for the same period in 2023, representing an increase of $0.6 million. The increase in corporate expenses was primarily due to higher stock-based compensation expenses and staff costs, as well as lower corporate allocations.
For the nine months ended September 30, 2024, corporate expenses were $3.2 million compared to $2.2 million for the same period in 2023, an increase of $1.1 million. The increase was primarily due to lower corporate allocations, partially offset by lower travel and entertainment expenses.
Depreciation and Amortization Expense
Depreciation and amortization expense was $0.4 million and $1.0 million for the three and nine months ended September 30, 2024, compared to $0.4 million and $1.1 million for the same periods in 2023, respectively.
Other Income (expense), Net
Other expense was $0.2 million and $0.3 million for the three and nine months ended September 30, 2024, respectively, as compared to other expense of $0.4 million and $0.3 million for the same periods in 2023. The lower net expense for the three months ended September 30, 2024 was primarily due to one-time client administrative costs of $0.3 million in the prior year.
Provision for Income Taxes
The provision for income taxes for the nine months ended September 30, 2024 was $0.5 million on $3.7 million of pre-tax income, compared to a provision for income tax of $1.1 million on $2.6 million of pre-tax income for the same period in 2023. The effective tax rates for the nine months ended September 30, 2024 and 2023 were negative 12% and positive 44%, respectively. For the nine months ended September 30, 2024, the effective tax rates differed from the U.S. Federal statutory rate of 21% primarily due to pretax losses for which no tax benefit can be recognized, foreign tax rate differences, and non-deductible expenses. For the nine months ended September 30, 2023, the effective tax rates differed from the U.S. Federal statutory rate of 21% primarily due to a discrete tax benefit recognized following the lapse of certain statutes of limitations related to Spain, recognition of a portion of a deferred tax asset in Canada, state income taxes, changes in valuation allowances in the U.S. and certain foreign jurisdictions which reduces or eliminates the effective tax rate on current year profits or losses, foreign tax rate differences, taxes on repatriations or deemed repatriation of foreign profits, and non-deductible expenses.
Net loss was $0.8 million for the three months ended September 30, 2024, compared to net income of $0.5 million for the three months ended September 30, 2023, a decrease in net income of $1.4 million. Basic and diluted loss per share were both $0.28 for the three months ended September 30, 2024, compared to basic and diluted earnings per share of $0.17 for the same period in 2023.
Net loss was $4.2 million for the nine months ended September 30, 2024, compared to net income of $1.5 million for the same period in 2023, a decrease in net income of $5.7 million. Basic and diluted loss per share were $1.39 for the nine months ended September 30, 2024, compared to basic and diluted earnings per share of $0.48 and $0.47, respectively, for the same period in 2023.
Liquidity and Capital Resources
As of September 30, 2024, cash and cash equivalents and restricted cash totaled $16.5 million, compared to $23.2 million as of December 31, 2023. The following table summarizes the Company’s cash flow activities for the nine months ended September 30, 2024 and 2023:
For the Nine Months Ended September 30,
$ in millions
2024
2023
Net cash used in operating activities
$
(4.8)
$
(3.0)
Net cash provided by (used in) investing activities
1.1
(0.1)
Net cash used in financing activities
(3.0)
(2.2)
Effect of exchange rates on cash, cash equivalents, and restricted cash
0.1
(0.2)
Net decrease in cash, cash equivalents, and restricted cash
$
(6.7)
$
(5.5)
Cash Flows from Operating Activities
For the nine months ended September 30, 2024, net cash used in operating activities was $4.8 million, compared to $3.0 million of net cash used in operating activities for the same period in 2023, resulting in a $1.8 million increase in net cash used. The increase in net cash used was principally driven by the Company’s lower net income in 2024, partially offset by more favorable working capital comparisons to the prior year.
Cash Flows from Investing Activities
For the nine months ended September 30, 2024, net cash provided by investing activities was $1.1 million compared to $0.1 million of net cash used in investing activities in 2023. Net cash provided by investing activities in 2024 reflects cash received from benefit payouts of $1.1 million.
Cash Flows from Financing Activities
For the nine months ended September 30, 2024, net cash used in financing activities was $3.0 million, compared to net cash used in financing activities of $2.2 million in 2023. The increase in net cash used was attributed to repurchases of shares of common stock of $2.8 million in 2024, including cash paid for tax withholdings, compared to the previous year.
On April 8, 2019, the Company’s Australian subsidiary (“Australian Borrower”) entered into an invoice finance credit facility agreement (the “NAB Facility Agreement”) with National Australia Bank Limited (“NAB”). The NAB Facility Agreement provides the Australian Borrower with the ability to borrow funds based on a percentage of eligible trade receivables up to a maximum of $4 million Australian dollars. No receivables have terms greater than 90 days, and any risk of loss is retained by the Australian Borrower. The interest rate is calculated as the variable receivable finance indicator rate, plus a margin of 1.60% per annum. Borrowings under this facility are secured by substantially all of the assets of the Australian Borrower. The NAB Facility Agreement does not have a stated maturity date and can be terminated by either the Australian Borrower or NAB upon 90 days written notice. As of September 30, 2024, there were no amounts outstanding under the NAB Facility Agreement. Interest expense and fees incurred on the NAB Facility Agreement were$4 and $13 for the three and nine months ended September 30, 2024, respectively, and $4 and $13 for the three and nine months ended September 30, 2023, respectively. The Australian Borrower was in compliance with all financial covenants under the NAB Facility Agreement as of September 30, 2024.
On May 25, 2022, Hudson Global Resources (Singapore) Pte. Ltd. (“Singapore Borrower”), which the Company acquired on October 31, 2023 (see Note 5 to the Consolidated Financial Statements in Item 8), and the Hong Kong and Shanghai Banking Corporation Limited (“HSBC”), entered into an invoice finance credit facility agreement (the “HSBC Facility Agreement”). The HSBC Facility Agreement allows the Singapore Borrower to borrow funds up to a maximum of 1 million Singapore dollars, based on a percentage of eligible trade receivables. All receivables have a term of no more than 60 days, and any risk of loss is borne by the Singapore Borrower. The interest rate is calculated as the bank’s external cost of capital, plus a margin of 3.5% per annum. The Company ended the HSBC Facility Agreement in May 2024. Interest expense and fees incurred on the HSBC Facility Agreement were $6 for the nine months ended September 30, 2024.
Liquidity and Capital Resources Outlook
As of September 30, 2024, the Company had cash and cash equivalents on hand of $15.8 million. The Company also has the capability to borrow an additional 4 million Australian dollars under the NAB Facility Agreement. Other than as described above, the Company has no financial guarantees, outstanding debt or other lease agreements or arrangements that could trigger a requirement for an early payment or that could change the value of our assets. The Company believes that it has sufficient liquidity to satisfy its needs through at least the next 12 months, based on the Company’s financial position as of September 30, 2024. The Company’s near-term cash requirements during 2024 are primarily related to the funding of the Company’s operations. For the full year 2024, the Company expects to make capital expenditures of less than $0.5 million.
As of September 30, 2024, $7.1 million of the Company’s cash and cash equivalents noted above were held in the U.S. and the remainder were held outside the U.S., primarily in Australia ($3.6 million), Philippines ($0.9 million), Singapore ($0.7 million), Belgium ($0.7 million), the U.K. ($0.7 million), Hong Kong ($0.7 million), and India ($0.5 million). The majority of the Company’s offshore cash is available to it as a source of funds, net of any tax obligations or assessments.
Off-Balance Sheet Arrangements
The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Contingencies
From time to time in the ordinary course of business, the Company is subject to compliance audits by U.S. federal, state, local, and foreign government regulatory, tax, and other authorities relating to a variety of regulations, including wage and hour laws, unemployment taxes, workers' compensation, immigration, and income, value-added, and sales taxes. The Company is also subject to, from time to time in the ordinary course of business, various claims, lawsuits, and other complaints from, for example, clients, candidates, suppliers, landlords for both leased and subleased properties, former and current employees, and regulators or tax authorities. Periodic events and management actions such as business reorganization initiatives can change the number and types of audits, claims, lawsuits, contract disputes, or complaints asserted against the Company. Such events can also change the likelihood of assertion and the behavior of third parties to reach resolution regarding such matters.
The economic conditions in the recent past have given rise to many news reports and bulletins from clients, tax authorities, and other parties about changes in their procedures for audits, payment, plans to challenge existing contracts, and other such matters aimed at being more aggressive in the resolution of such matters in their own favor. The Company believes
that it has appropriate procedures in place for identifying and communicating any matters of this type, whether asserted or likely to be asserted, and it evaluates its liabilities in light of the prevailing circumstances. Changes in the behavior of third parties could cause the Company to change its view of the likelihood of a claim and what might constitute a trend. Employment laws vary in the markets in which we operate, and in some cases, employees and former employees have extended periods during which they may bring claims against the Company.
For matters that reach the threshold of probable and estimable, the Company establishes reserves for legal, regulatory, and other contingent liabilities. The Company did not have any reserves as of September 30, 2024 and December 31, 2023. Although the outcome of these matters cannot be determined, the Company believes that none of the currently pending matters, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition, results of operations or liquidity.
Recent Accounting Pronouncements
See Note 3 to the Condensed Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q for a full description of relevant accounting pronouncements, including the respective expected dates of adoption.
Critical Accounting Estimates
See “Critical Accounting Estimates” under Item 7 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC on March 14, 2024 and incorporated by reference herein. There were no changes to the Company’s critical accounting policies or estimates during the nine months ended September 30, 2024.
FORWARD-LOOKING STATEMENTS
This Form 10-Q contains statements that the Company believes to be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this Form 10-Q, including statements regarding the Company’s future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “predict,” “believe,” and similar words, expressions, and variations of these words and expressions are intended to identify forward-looking statements. All forward-looking statements are subject to important factors, risks, uncertainties, and assumptions, including industry and economic conditions that could cause actual results to differ materially from those described in the forward-looking statements. Such factors, risks, uncertainties, and assumptions include, but are not limited to, (1) global economic fluctuations, (2) the Company’s ability to successfully achieve its strategic initiatives, (3) risks related to potential acquisitions or dispositions of businesses by the Company, (4) the Company’s ability to operate successfully as a company focused on its RPO business, (5) risks related to fluctuations in the Company’s operating results from quarter to quarter due to various factors such as rising inflationary pressures and interest rates, (6) the loss of or material reduction in our business with any of the Company’s largest customers, (7) the ability of clients to terminate their relationship with the Company at any time, (8) competition in the Company’s markets, (9) the negative cash flows and operating losses that may recur in the future, (10) risks relating to how future credit facilities may affect or restrict our operating flexibility, (11) risks associated with the Company’s investment strategy, (12) risks related to international operations, including foreign currency fluctuations, political events, natural disasters or health crises, including the Russia-Ukraine war, the Hamas-Israel war, and potential conflict in the Middle East, (13) the Company’s dependence on key management personnel, (14) the Company’s ability to attract and retain highly skilled professionals, management, and advisors, (15) the Company’s ability to collect accounts receivable, (16) the Company’s ability to maintain costs at an acceptable level, (17) the Company’s heavy reliance on information systems and the impact of potentially losing or failing to develop technology, (18) risks related to providing uninterrupted service to clients, (19) the Company’s exposure to employment-related claims from clients, employers and regulatory authorities, current and former employees in connection with the Company’s business reorganization initiatives, and limits on related insurance coverage, (20) the Company’s ability to utilize net operating loss carryforwards, (21) volatility of the Company’s stock price, (22) the impact of government regulations, (23) restrictions imposed by blocking arrangements, (24) risks related to the use of new and evolving technologies, (25) the adverse impacts of cybersecurity threats and attacks and (26) those risks set forth in “Risk Factors in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.” The foregoing list should not be construed to be exhaustive. Actual results could differ materially from the forward-looking statements contained in this Form 10-Q. In view of these uncertainties, you should not place undue reliance on any forward-looking statements, which are based on our current expectations. These forward-looking statements speak only as of the date of this Form 10-Q. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information required under this Item.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the design and operation of the Company’s disclosure controls and procedures, as such term is defined under Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended. Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2024. However, such controls and procedures are designed only to provide reasonable assurance. There is no complete assurance that these controls and procedures will operate effectively under all circumstances.
Changes in Internal Control Over Financial Reporting
There were no changes in the Company’s internal control over financial reporting that occurred during the nine months ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
The Company is subject, from time to time, to various legal proceedings that are incidental to the conduct of its business. The Company is not involved in any pending legal proceeding that it believes would reasonably be expected to have a material adverse effect on its financial condition or results of operations.
ITEM 1A. RISK FACTORS
In evaluating us and our common stock, we urge you to carefully consider the risks and other information in this Quarterly Report on Form 10-Q, the Risk Factors disclosed in Item 1A. of Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as well as additional risks and uncertainties not currently known to us or that we currently deem immaterial, that could materially and adversely affect our results of operations or financial condition.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Repurchases of Shares
The following table summarizes purchases of common stock by the Company during the quarter ended September 30, 2024.
Period
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (a)
July 1, 2024 - July 31, 2024
—
$
—
—
$
2,495,145
August 1, 2024 - August 31, 2024
5,164
$
18.09
5,164
$
2,401,734
September 1, 2024 - September 30, 2024
17,482
$
16.19
17,482
$
2,118,651
Total
22,646
$
16.63
22,646
(a)On July 30, 2015, the Company announced that its Board authorized the repurchase of up to $10 million of the Company’s common stock. On August 8, 2023, the Company’s Board of Directors authorized a new stock repurchase program for up to $5 million of the Company’s outstanding shares of common stock. This authorization does not expire. The Company has repurchased shares from time to time as market conditions warrant.
Under the new stock repurchase program, the Company intends to repurchase shares through open market purchases, privately negotiated transactions, block purchases, or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934 (the “Exchange Act”). Further details can be found in Note 13 to the Condensed Consolidated Financial Statements in Item 1 included in Part I of this Form 10-Q.
During the nine months ended September 30, 2024, the Company repurchased a total of 154,084 shares of its common stock for a cost of $2.5 million under this authorization. Of these shares, 44,250 shares were repurchased on January 29, 2024 in connection with a transaction with a certain shareholder totaling $0.7 million that excludes tax withholdings. The Company also repurchased 69,567 shares during the second quarter in connection with transactions with certain shareholders totaling $1.2 million, as well as 40,267 shares of its common stock on the open market for a cost of $0.7 million. For the nine months ended September 30, 2023, the Company repurchased 36,842 shares of its common stock on the open market for $0.8 million. As of September 30, 2024, under the July 30, 2015 and August 8, 2023 authorizations combined, the Company had repurchased an aggregate of 667,496 shares for a total cost of $12.9 million, completing the July 30, 2015 authorization and leaving $2.1 million available for purchase under the August 8, 2023 authorization.
The following materials from Hudson Global, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 are filed herewith, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Operations for the three months and nine months ended September 30, 2024 and 2023, (ii) the Condensed Consolidated Statements of Other Comprehensive Income (Loss) for the three months and nine months ended September 30, 2024 and 2023, (iii) the Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023, (iv) the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023, (v) the Condensed Consolidated Statements of Stockholders’ Equity for the three months and nine months ended September 30, 2024 and 2023, and (vi) Notes to Condensed Consolidated Financial Statements.
104*
The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, formatted in iXBRL and contained in Exhibit 101.
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.